TrialTrials2014

A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.

Samal Gunatilake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.